DUOX2 and gastric cancer: In an effort to develop a pre-clinical model to evaluate the potential application of chemopotentiation by Low Dose Fractionated Radiation Therapy (LDFRT) for disseminated gastric cancer, the human stomach cancer NCI-N87 cells expressing endogenous or reduced DUOX2 levels (Figure 1C) were then injected orthotopically in the abdomen of mice and treated, as described in the Material and Methods.